Pfizer (NYSE:PFE) - Page 2

The Stock Market Is Very Expensive: 5 Safe Blue Chips to Buy Now

By any measure, the eight-and-a-half-year-old bull market is getting tired, and after one of the biggest percentage runs in stock market history, it may be time for investors to move ...
Read Full Story »

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) a close ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

Stocks were indicated marginally higher on Thursday after the European Central Bank statement remained quite dovish. The major equity indexes all remain just under all-time highs. Even though this bull ...
Read Full Story »

IBM, JPMorgan Weigh on DJIA Monday

July 17, 2017: Markets opened mixed Monday and never strayed far from the break-even line. The best performing sectors were Utilities and consumer discretionaries while healthcare was the laggard. WTI ...
Read Full Story »

Major Pharma Short Sellers Become More Selective

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

FDA Issues an Approval Not Seen in Almost 20 Years

In an incredible move on Friday, the U.S. Food and Drug Administration (FDA) approved Endari for the treatment of patients age five and older with sickle cell disease to reduce ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

25 Great American Companies Paying High Dividends

Investors love dividends. Whether the market is up or down, many investors need those dividends to help pay income in retirement. Dividends also account for up to half of all ...
Read Full Story »

The Top 20 S&P 500 Companies Buying Back Stock in 2017

Long-term investors have generally been a fan of stock buybacks and dividends. After all, dividends can account for about half of all shareholder returns over time. And buybacks can help ...
Read Full Story »

Short Sellers Grow More Selective on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Cisco Systems, United Technologies Weigh on DJIA Monday

June 5, 2017: Markets opened lower Monday following a report that several Middle East oil producing nations have cut ties with Qatar due to that country's support for terrorism. The ...
Read Full Story »

Top Presentations to Look for at ASCO

It almost the end of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2017 annual meeting ...
Read Full Story »

Big Pharma Has Big Catalysts Coming for the Rest of 2017

The big pharmaceutical stocks are one area that has done somewhat better this year. One major reason for that is the shrill rhetoric from politicians has quieted as the election ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

10 Stocks Analysts Want You to Sell

Now that the bull market is more than eight years old and many of the pro-growth policies out of Washington may be muted or delayed, many investors are wondering how they ...
Read Full Story »